IBDEI30Q ; ; 19-NOV-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,50599,2)
 ;;=^5008245
 ;;^UTILITY(U,$J,358.3,50600,0)
 ;;=J45.41^^219^2457^24
 ;;^UTILITY(U,$J,358.3,50600,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,50600,1,3,0)
 ;;=3^Moderate Persistent Asthma w/ Exacerbation
 ;;^UTILITY(U,$J,358.3,50600,1,4,0)
 ;;=4^J45.41
 ;;^UTILITY(U,$J,358.3,50600,2)
 ;;=^5008249
 ;;^UTILITY(U,$J,358.3,50601,0)
 ;;=J45.42^^219^2457^25
 ;;^UTILITY(U,$J,358.3,50601,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,50601,1,3,0)
 ;;=3^Moderate Persistent Asthma w/ Status Asthmaticus
 ;;^UTILITY(U,$J,358.3,50601,1,4,0)
 ;;=4^J45.42
 ;;^UTILITY(U,$J,358.3,50601,2)
 ;;=^5008250
 ;;^UTILITY(U,$J,358.3,50602,0)
 ;;=J45.40^^219^2457^26
 ;;^UTILITY(U,$J,358.3,50602,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,50602,1,3,0)
 ;;=3^Moderate Persistent Asthma,Uncomplicated
 ;;^UTILITY(U,$J,358.3,50602,1,4,0)
 ;;=4^J45.40
 ;;^UTILITY(U,$J,358.3,50602,2)
 ;;=^5008248
 ;;^UTILITY(U,$J,358.3,50603,0)
 ;;=J41.1^^219^2457^27
 ;;^UTILITY(U,$J,358.3,50603,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,50603,1,3,0)
 ;;=3^Mucopurulent Chr Bronchitis
 ;;^UTILITY(U,$J,358.3,50603,1,4,0)
 ;;=4^J41.1
 ;;^UTILITY(U,$J,358.3,50603,2)
 ;;=^269949
 ;;^UTILITY(U,$J,358.3,50604,0)
 ;;=J45.998^^219^2457^2
 ;;^UTILITY(U,$J,358.3,50604,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,50604,1,3,0)
 ;;=3^Asthma NEC
 ;;^UTILITY(U,$J,358.3,50604,1,4,0)
 ;;=4^J45.998
 ;;^UTILITY(U,$J,358.3,50604,2)
 ;;=^5008257
 ;;^UTILITY(U,$J,358.3,50605,0)
 ;;=J43.8^^219^2457^15
 ;;^UTILITY(U,$J,358.3,50605,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,50605,1,3,0)
 ;;=3^Emphysema NEC
 ;;^UTILITY(U,$J,358.3,50605,1,4,0)
 ;;=4^J43.8
 ;;^UTILITY(U,$J,358.3,50605,2)
 ;;=^87569
 ;;^UTILITY(U,$J,358.3,50606,0)
 ;;=J43.1^^219^2457^28
 ;;^UTILITY(U,$J,358.3,50606,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,50606,1,3,0)
 ;;=3^Panlobular Emphysema
 ;;^UTILITY(U,$J,358.3,50606,1,4,0)
 ;;=4^J43.1
 ;;^UTILITY(U,$J,358.3,50606,2)
 ;;=^5008236
 ;;^UTILITY(U,$J,358.3,50607,0)
 ;;=J45.51^^219^2457^29
 ;;^UTILITY(U,$J,358.3,50607,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,50607,1,3,0)
 ;;=3^Severe Persistent Asthma w/ Exacerbation
 ;;^UTILITY(U,$J,358.3,50607,1,4,0)
 ;;=4^J45.51
 ;;^UTILITY(U,$J,358.3,50607,2)
 ;;=^5008252
 ;;^UTILITY(U,$J,358.3,50608,0)
 ;;=J45.52^^219^2457^30
 ;;^UTILITY(U,$J,358.3,50608,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,50608,1,3,0)
 ;;=3^Severe Persistent Asthma w/ Status Asthmaticus
 ;;^UTILITY(U,$J,358.3,50608,1,4,0)
 ;;=4^J45.52
 ;;^UTILITY(U,$J,358.3,50608,2)
 ;;=^5008253
 ;;^UTILITY(U,$J,358.3,50609,0)
 ;;=J45.50^^219^2457^31
 ;;^UTILITY(U,$J,358.3,50609,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,50609,1,3,0)
 ;;=3^Severe Persistent Asthma,Uncomplicated
 ;;^UTILITY(U,$J,358.3,50609,1,4,0)
 ;;=4^J45.50
 ;;^UTILITY(U,$J,358.3,50609,2)
 ;;=^5008251
 ;;^UTILITY(U,$J,358.3,50610,0)
 ;;=J43.0^^219^2457^32
 ;;^UTILITY(U,$J,358.3,50610,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,50610,1,3,0)
 ;;=3^Unilateral Pulmonary Emphysema
 ;;^UTILITY(U,$J,358.3,50610,1,4,0)
 ;;=4^J43.0
 ;;^UTILITY(U,$J,358.3,50610,2)
 ;;=^5008235
 ;;^UTILITY(U,$J,358.3,50611,0)
 ;;=J45.901^^219^2457^3
 ;;^UTILITY(U,$J,358.3,50611,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,50611,1,3,0)
 ;;=3^Asthma w/ Exacerbation,Unspec
 ;;^UTILITY(U,$J,358.3,50611,1,4,0)
 ;;=4^J45.901
 ;;^UTILITY(U,$J,358.3,50611,2)
 ;;=^5008254
 ;;^UTILITY(U,$J,358.3,50612,0)
 ;;=J45.902^^219^2457^4
 ;;^UTILITY(U,$J,358.3,50612,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,50612,1,3,0)
 ;;=3^Asthma w/ Status Asthmaticus,Unspec
 ;;^UTILITY(U,$J,358.3,50612,1,4,0)
 ;;=4^J45.902
